Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results ...

A new way of treating heart failure patients at Mercy Hospital Washington has been a major success, according to the doctor ...

Patients with heart failure are often advised to limit or avoid alcohol consumption altogether, as it can interfere with ...

Reimbursement rate to increase 397% per day effective January 1, 2025New rate expected to encourage adoption of ultrafiltration therapy in the ...

SeeMedX Inc. ("SeeMedX") today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug ...

Doctors often recommend that heart patients monitor their fluid intake to avoid overhydration. The key is to strike a balance between staying hydrated and preventing fluid overload. Dehydration can ...

Nuwellis (NUWE) announces that University of Iowa Health Care Stead Family Children’s Hospital in Iowa City, Iowa, has adopted the ...

Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that University of Iowa Health Care Stead Family ...

Ghent, Belgium, 23 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Objective Recent evidence suggests that fluid overload may be deleterious to critically ill children. The purpose of this study was to investigate the association of early fluid overload with ...

up to 261,895 new shares can be issued upon the exercise of 90,780 share options that are still outstanding under the 'Executive Share Options' plan for staff members and consultants of the Company, ...